Free Trial

Yuanbao (NASDAQ:YB) Stock Price Up 6.4% - Should You Buy?

Yuanbao logo with Finance background

Shares of Yuanbao Inc. - Sponsored ADR (NASDAQ:YB - Get Free Report) traded up 6.4% on Thursday . The stock traded as high as $22.25 and last traded at $22.18. 91,848 shares traded hands during trading, a decline of 10% from the average session volume of 102,224 shares. The stock had previously closed at $20.85.

Analysts Set New Price Targets

Separately, Wall Street Zen lowered shares of Yuanbao from a "buy" rating to a "hold" rating in a research note on Sunday, June 15th.

Get Our Latest Stock Analysis on YB

Yuanbao Stock Up 6.6%

Yuanbao (NASDAQ:YB - Get Free Report) last issued its quarterly earnings data on Thursday, June 5th. The company reported $0.89 earnings per share (EPS) for the quarter. The firm had revenue of $133.68 million for the quarter.

Yuanbao Company Profile

(Get Free Report)

Our mission is to protect health and well-being through technology. We are a leading technology-driven online insurance distributor in China. We take pride in pioneering the seamless integration of insurance with cutting-edge technologies, and have constructed a highly efficient full consumer service cycle engine.

Read More

Should You Invest $1,000 in Yuanbao Right Now?

Before you consider Yuanbao, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Yuanbao wasn't on the list.

While Yuanbao currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines